Status | Study |
Not yet recruiting |
Study Name: Duration of Doxycycline Treatment in EM Patients Condition: Erythema Chronicum Migrans Date: 2017-03-16 Interventions: Drug: Doxycycline 100 MG Oral Tablet bid, 7 days |
Completed |
Study Name: Lyme Borreliosis and Early Cutaneous Diagnostic Condition: Erythema Migrans Date: 2015-04-08 Interventions: Procedure: Skin biopsies Skin biopsies of patients with Lyme disease (erythema migrans) infected with Bo |
Recruiting |
Study Name: Cytokines and Chemokines in Erythema Migrans Condition: Erythema Migrans Date: 2013-06-24 Interventions: Drug: antibiotic treatment Patient will be treated with: doxycycline orally, 100 mg, bid, 14 days or cef |
Completed |
Study Name: Culture Media for Borrelia Burgdorferi Sensu Lato Condition: Erythema Migrans Date: 2013-06-24 Interventions: Other: MKP media one half of s |
Completed |
Study Name: Doxycycline in Therapy of Erythema Migrans Condition: Lyme Borreliosis Date: 2011-11-16 Interventions: Drug: Doxycycline 100 mg PO bid, 14 days Other Name: |
Recruiting |
Study Name: The Relationship Between Allergic Rhinitis and Geographic Tongue Condition: Allergic Rhinitis Geographic Tongue Date: 2011-10-04 |
Completed |
Study Name: Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice Condition: Erythema Migrans Erythema Chronicum Migrans Date: 2011-06-06 Interventions: Drug: Doxycycline 1 tablet, 10 |
Recruiting |
Study Name: Antibiotic Treatment of Multiple Erythema Migrans Condition: Multiple Erythema Migrans Date: 2010-07-13 Interventions: Drug: ceftriaxone intravenousl |
Completed |
Study Name: Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome Condition: Erythema Migrans Post-Lyme Disease Symptoms Date: 2010-06-28 Interventions: Drug: doxycycline 100 mg bid; |
Recruiting |
Study Name: Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis Condition: Suspected Early Lyme Neuroborreliosis Date: 2009-07-17 Interventions: Drug: doxycycline 100 mg bid, |